Navigation Links
Medical Marijuana, Inc. Portfolio Company PhytoSPHERE Systems Announces Successful Production of Hemp Harvesting for High Value CBD Oil
Date:9/7/2012

SAN DIEGO, Sept. 7, 2012 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), a leading hemp industry innovator, is pleased to announce that its portfolio company PhytoSPHERE Systems, which develops pharmaceutical grade medicinal hemp production facilities that produce high grade oil, is harvesting 1,000 acres of Hemp from its microclimate fields throughout Europe.

In the coming months, the crops will produce in excess of 2,000 kilograms of raw Hemp oil that will be used to fill new and existing contracts. The crops will provide high concentrate Hemp cannabidiol (CBD) oil for another MJNA portfolio company, Red Dice Holdings. Red Dice Holdings will then use the oil to fulfill orders for its Dixie X products— three new Hemp-based medical delivery systems that have the potential to deliver pain relief without the psychotropic effects of THC. To read more about the medical benefits and studies of Hemp-based CBD please click the following links:

"We are pleased to be ahead of schedule with the harvesting of several of our Hemp crops. The harvest will enable us to produce a large-scale quantity of Hemp oil for our newly launched Dixie X product line and our soon to be launched patented CanChew medicinal gum, both of which rely on Hemp-based CBD instead of THC thus eliminating psychoactive effects.  In many ways, we see our Hemp-based medical delivery systems as the future of our industry for the millions of patients who desire CBD wellness products," said Michael Llamas, President of Medical Marijuana, Inc.

Please visit this link for photos of the most recent harvest: http://www.medicalmarijuanainc.com/index.php/pictures

About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value.

Medical Marijuana, Inc. does not grow, sell or distribute any substances that violate United States Law or the controlled substance act.

For more information, please visit the company's website at:
www.MedicalMarijuanaInc.com

About PhytoSPHERE Systems, LLC
PhytoSPHERE Systems, LLC is the world's leading cannabinoid based Hemp biotechnology company that builds and develops growing, packaging and extraction technologies and deploys them in self-contained, highly efficient state of the art facilities as well as traditional hemp agricultural facilities, for the pharmaceutical and neutraceutical raw ingredients markets. PhytoSPHERE Systems has documented over 200 industrial hemp varieties and has identified specific ones with the highest levels of Cannabidiol for further development and production by PhytoSPHERE Systems

PhytoSPHERE's highly efficient growth, packaging and extraction technologies provide clients with a compact, safe, pollutant-free facility.

FORWARD-LOOKING DISCLAIMER
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the Food and Drug Administration (FDA). These products and statements are not intended to diagnose, treat, cure, or prevent any disease.

Corporate Contact:

Medical Marijuana, Inc.
Toll Free: 888-OTC-MJNA (888-682-6562)
www.medicalmarijuanainc.com
www.facebook.com/mjnainc

Investor Relations Contact:

Stuart T. Smith
SmallCapVoice.Com, Inc.
P. 512-267-2430
F. 512-267-2530
Email: ssmith@smallcapvoice.com
Skype: SmallCapVoice.com
AIM: SmallCapVoice7

 

 

 


'/>"/>
SOURCE Medical Marijuana, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. AFCell Medical Reports Results from the Retrospective Study of a Novel Allograft Membrane to Prevent Post-Operative Adhesions in the Repair of Peroneal and Posterior Tibial Tendons
2. Tufts Medical Center Announces Inaugural INNOVATION Day: Innovating a Path to Market
3. Texas Medical Center, the largest concentration of medical research, educational and healthcare organizations in the world, announces the first Houston Stem Cell Summit to highlight the latest stem cell research and commercialization efforts
4. Global Medical Laboratories Industry
5. MarketsandMarkets: Global Refurbished Medical Equipments Market worth $8.45 Billion by 2017
6. Medical Marijuana Inc. Product, CanChew Bio-Technologies
7. The Leukemia & Lymphoma Society Awards $12 Million in Research Grants in Four Critical Areas of Unmet Medical Need
8. Elsevier / MEDai Names Dr. Peter Edelstein as Chief Medical Officer and Dr. Gerald Osband as Director of Product Strategy
9. Former FDA Inspectors Train Medical Device, Pharmaceutical Companies How to Prepare for FDA Inspections of Their Quality Systems
10. Department of Defense Exercises Options Under Contract for Nerve Agent Medical Countermeasure Program
11. Chicago Celebrates First Informatics Week, Co-Chaired by Intelligent Medical Objects and Northwestern University
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... (PRWEB) , ... May 25, 2016 , ... Scientists at ... line options being tried for mesothelioma may be hampering the research that could lead ... research. Click here to read it now. , The team evaluated 98 ...
(Date:5/25/2016)... ... May 25, 2016 , ... Biohaven Pharmaceutical Holding Company ... granted the company’s orphan drug designation request covering BHV-4157 for the treatment of ... the FDA. , Spinocerebellar ataxia is a rare, debilitating neurodegenerative disorder that ...
(Date:5/24/2016)... (PRWEB) , ... May 24, 2016 , ... Last week, ... for corporate executives and entrepreneurs, held The Future of San Diego Life Science event ... San Diego life science community attended the event with speakers Dr. Rich Heyman, former ...
(Date:5/23/2016)... ... May 23, 2016 , ... PrecisionAg® ... Farming in 2017 and Beyond. The paper outlines the key trends that are ... industry. , “We’ve witnessed a lot of highs and lows as the precision ...
Breaking Biology Technology:
(Date:3/11/2016)... -- http://www.apimages.com ) - --> http://www.apimages.com ) ... AP Images ( http://www.apimages.com ) - Germany ... the new refugee identity cards. DERMALOG will be unveiling this device, ... Hanover next week.   --> Germany ... produce the new refugee identity cards. DERMALOG will be unveiling this ...
(Date:3/10/2016)... India , March 10, 2016 ... a new market research report "Identity and Access Management ... & Audit, Compliance, and Governance), by Organization Size, by ... to 2020", published by MarketsandMarkets, The market is estimated ... USD 12.78 Billion by 2020, at a Compound Annual ...
(Date:3/9/2016)... 9, 2016 This BCC Research report provides ... the RNA Sequencing (RNA Seq) market for the years ... tools and reagents, data analysis, and services. ... the RNA-Sequencing market such as RNA-Sequencing tools and reagents, ... factors affecting each segment and forecast their market growth, ...
Breaking Biology News(10 mins):